Jagsonpal Pharmaceutical launches QueeZy-ER

08 Mar 2024 Evaluate

Jagsonpal Pharmaceutical has launched QueeZy-ER providing relief from Nausea and Vomiting in Pregnancy (NVP). The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation. The product comes with a tablet-intablet technology, which allows dispersal of uniform dosage at two different time-periods from the same dose, thereby allowing for 24-hour benefit to the patient. This allows for a single dose as against the conventional requirement of up to 3-4 tablets a day.

Further, the overall therapy cost per day is lower as compared to conventional pills. The combination of Doxylamine succinate 20mg and Pyridoxine hydrochloride 20mg is the only USFDA approved combination for NVP treatment. Queezy-ER is now available in leading pharmacies across India.

Jagsonpal Pharmaceutical is among India’s premiere pharmaceutical companies.

Jagsonpal Pharma Share Price

330.15 -12.35 (-3.61%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.